E44: This week, Eric Snyder from the Wilmot Cancer Institute explains how he called BS on all the SaaS vendors selling half baked solutions into healthcare, built his own internal team, and developed a complete solution that the internal staff embraced and love. The result? They're saving millions of dollars per year vs using SaaS subscriptions and won the Galien Award, which is the Nobel Prize equivalent for healthcare. Expect this trend to continue as more people from other industries enter healthcare, bringing practical thinking and logical solutions to solve problems that have been deliberately over complicated in the past.
关于我们
Highlighting transformative healthtech solutions and senior executives who are not afraid of driving bold initiatives to improve healthcare. Each week we feature important information, critical thinking, and sometimes blunt criticism of the U.S. healthcare system that cannot be ignored. Concise, succinct, and highly edited to about 5 minutes each Monday.
- 网站
-
www.vaxshow.com
TheVax的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Dallas,TX
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
US,TX,Dallas
动态
-
E43: Remember the old days when doctors used to spend 1-2 hours each day on paperwork, notes, prescriptions and other documents? (If you're still doing this, don't admit it to anyone!) This week Arpit Rao, MD shares how Ankr Health has eliminated that nonsense so call them and get your life back!
-
E42: Ketamine and Magic Mushrooms to treat mental health patients?! Sherry Rais shocked me when she explained how she is driving LEGAL access to this controversial therapy but her positive results blew me away. The statistics are irrefutable and this points to much broader access across the country in the future. For tens of millions of Americans suffering from mental health issues, Enthea offers transformative hope. Give this woman some major thumbs up!
-
E41: 6X Healthtech founding CEO David Norris emerges from Stealth mode this week with AI Inbox automation and substantial early customer traction from providers who lead innovation. Meet Affineon Health and in the comments please tell me if you find these features informative and why. I try to present concise facts with no fluff.
-
E40: “The vendors are controlling the narrative.” Jason Taylor nailed it this week with that comment and he's right. Panda Health has created a report card on all those vendors to help you discern Fact - Fiction - Fantasy. Before taking a leap of faith, it might be wise to check out that vendor's grade!
-
E39: Imagine having a team of pedigreed senior executives as your personal advisors, steering your career toward the C-Suite, helping you secure the right board positions and charity committees, then certifying you and endorsing you along your career. I was never so lucky! Raquel Ortiz, MHA recently showed me how NALHE is preparing mid-level leaders in healthcare for a seat at the table... The BOARDROOM table. Check out the Ascender program!
-
E38: The process of shepherding new drugs through the FDA regulatory process just changed forever. This week Dave Latshaw II, PhD, MBA from BioPhy reveals one of the best applications for AI that I have seen all year, saving the average drug company tens of millions of dollars for each new drug developed. Somebody get this man a superhero outfit!
-
E37: It's great to hear a Healthcare CIO like Nayan D. Patel, CHCIO, CDH-E, FHIMSS talk about managing change from a "Have to Have vs Nice to Have" lens and guiding clinicians through automation changes that create new KPIs, and new levels of efficiency. Overcoming human fear of change and resistance to technology is perhaps the biggest hurdle the industry faces over the next 7 years and it takes people skills like this to drive transformation.
-
E35: This week Healthtech sales champion and coach James Lakes shares insight on what sales reps often do wrong, the need for quantifiable evidence that proves product ROI, leading vs. lagging indicators, and focusing on scoring points rather than winning the game. Post your thoughts and add your two cents in the comments.